Noriko Doki

3.6k citations
181 papers · 1.5k indexed · h-index 18

Noriko Doki

154 papers receiving 1.5k citations

Peers

Noriko Doki
Comparison fields: 5 of 96
  • Hematology 894
  • Transplantation 68
  • Genetics 223
  • Immunology 278
  • Oncology 324
Replace Kazuhiko Kakihana with:
Kazuhiko Kakihana Japan
Éolia Brissot France
Raffaella Cerretti Italy
Jiří Pavlů United Kingdom
Kyoo‐Hyung Lee South Korea
Jihyang Lim South Korea
Woo-Sung Min South Korea
Christelle Ferrá Spain
Panagiotis Tsirigotis Greece
Donna Salzman United States
Noriko Doki relative to Kazuhiko Kakihana Japan Kazuhiko Kakihana's profile →
Citations per field
00.5×2.6×
Kazuhiko Kakihana · 1×
Citations per year

Countries citing papers authored by Noriko Doki

Since Specialization
Citations

This map shows the geographic impact of Noriko Doki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Doki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Doki more than expected).

Fields of papers citing papers by Noriko Doki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriko Doki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Doki. The network helps show where Noriko Doki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Noriko Doki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Noriko Doki Line = papers co-authored together Noriko Doki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20240
5 20240
6 20242
7 20242
8 20240
9 20230
10 20231
11 20234
12 20231
13 20232
14 20232
15 20226
16 202115
17 20219
18 20212
19 202012
20 2014111

About Noriko Doki

Noriko Doki is a scholar working on Hematology, Genetics, Transplantation, Public Health, Environmental and Occupational Health and Immunology, having authored 181 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (98 papers), Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (44 papers), Chronic Myeloid Leukemia Treatments (36 papers), Immune Cell Function and Interaction (23 papers), Cytomegalovirus and herpesvirus research (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Neutropenia and Cancer Infections (12 papers). The work is most often cited by research in Hematology (894 citations), Transplantation (68 citations), Genetics (223 citations), Immunology (278 citations) and Oncology (324 citations). Noriko Doki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Kazuhiko Kakihana, Kazuteru Ohashi, Yuho Najima, Yoshiko Atsuta, Hisashi Sakamaki, Takeshi Kobayashi, Makoto Onizuka, Takashi Toya, Takahiro Fukuda and Yutaro Hino. Their work appears in journals such as International Journal of Hematology, Bone Marrow Transplantation, Blood, Transplantation and Cellular Therapy and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026